EFFECT OF CHRONIC-RENAL-FAILURE ON HIGH-DENSITY-LIPOPROTEIN KINETICS

被引:46
|
作者
FUH, MMT
LEE, CM
JENG, CY
SHEN, DC
SHIEH, SM
REAVEN, GM
CHEN, YDI
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,STANFORD,CA 94305
[2] NATL DEF MED CTR,TRI SERV GEN HOSP,DEPT MED,TAIPEI,TAIWAN
[3] NATL DEF MED CTR,TRI SERV GEN HOSP,CLIN RES LAB,TAIPEI,TAIWAN
关键词
D O I
10.1038/ki.1990.114
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Plasma lipid and lipoprotein concentration and high density lipoprotein (HDL) kinetics were determined in control subjects and patients with chronic renal failure (CRF). Results demonstrated that plasma triglyceride (TG) concentration was significantly higher (P < 0.001) in patients with CRF, associated with a significant increase in plasma VLDL-cholesterol (P < 0.002) and a significant decrease (P < 0.05) in plasma HDL-cholesterol concentration. The rate of removal of 125I-apoAI/ HDL from plasma was slower (P < 0.001) in the patients with CRF, resulting in an increase in the residence time of 125I-apoAI/HDL (P < 0.001) and a decrease in the fractional catabolic rate (P < 0.001). Since plasma apoAI concentration was lower in patients with CRF, total apoAI/HDL synthetic rate was also significantly (P < 0.05) decreased. These data provide support for the view that low plasma HDL-cholesterol concentrations in patients with CRF are related to decreases in the synthetic rate of apoAI/HDL.
引用
收藏
页码:1295 / 1300
页数:6
相关论文
共 50 条
  • [31] CHRONIC-RENAL-FAILURE
    KURUVILA, KC
    SCHRIER, RW
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 1984, 22 (01) : 101 - 120
  • [32] THE EFFECT OF ERYTHROPOIETIN ON THE PROGRESSION OF CHRONIC-RENAL-FAILURE
    EIDEMAK, I
    FRIEDBERG, M
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 505 - 505
  • [33] CHRONIC-RENAL-FAILURE
    FALLON, K
    JOURNAL OF MEDICAL TECHNOLOGY, 1987, 4 (06): : 230 - 233
  • [34] EFFECT OF IBOPAMINE ON THE PROGRESSION OF CHRONIC-RENAL-FAILURE
    DOCCI, D
    PISTOCCHI, E
    TURCI, F
    BALDRATI, L
    CLINICAL NEPHROLOGY, 1986, 26 (03) : 121 - 124
  • [35] EFFECT OF CAPD ON THE HYPERLIPEMIA OF CHRONIC-RENAL-FAILURE
    HEATON, A
    TISDALL, S
    RAMOS, JM
    MCGURK, J
    WARD, MK
    KERR, DNS
    KIDNEY INTERNATIONAL, 1984, 26 (04) : 563 - 563
  • [36] SERUM LIPOPROTEIN(A) AND DYSLIPIDEMIA IN PATIENTS WITH CHRONIC-RENAL-FAILURE RECEIVING HEMODIALYSIS
    CHO, HS
    LEE, KS
    NAM, SY
    KIM, HS
    HA, SK
    LEE, HY
    HAN, DS
    KIM, JH
    KIDNEY INTERNATIONAL, 1993, 44 (05) : 1187 - 1187
  • [37] LIPOPROTEIN CHANGES BEFORE AND AFTER HEMODIALYSIS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    OZUER, M
    BERK, O
    ISIK, E
    KIDNEY INTERNATIONAL, 1981, 19 (01) : 104 - 104
  • [38] LIPOPROTEIN ABNORMALITIES IN HYPERLIPIDEMIC AND NORMOLIPIDEMIC MEN ON HEMODIALYSIS WITH CHRONIC-RENAL-FAILURE
    SENTI, M
    ROMERO, R
    PEDROBOTET, J
    PELEGRI, A
    NOGUES, X
    RUBIESPRAT, J
    KIDNEY INTERNATIONAL, 1992, 41 (05) : 1394 - 1399
  • [39] EFFECT OF ALCOHOL ON LIPOPROTEIN METABOLISM .1. HIGH-DENSITY-LIPOPROTEIN BINDING
    PARKES, JG
    HUSSAIN, RA
    GOLDBERG, DM
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1989, 7 (06) : 269 - 277
  • [40] SALSALATE KINETICS IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING HEMODIALYSIS
    WILLIAMS, ME
    WEINBLATT, M
    ROSA, RM
    GRIFFIN, VL
    GOLDLUST, MB
    SHANG, SF
    HARRISON, LI
    BROWN, RS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (04) : 420 - 424